Skip to Main content Skip to Navigation
Journal articles

Influence of muramyl dipeptide on established experimental arthritis in rats.

Abstract : The effects of MDP, a potent inducer of cytokines, were studied in four batches of Wistar Furth rats with established experimental arthritis. Arthritic rats were given a daily sc injection of 10, 100, 200 or 400 micrograms MDP respectively. Muramyl dipeptide increased the severity of clinical events in a dose-dependent manner, with the exception of the 10 micrograms dose which was ineffective. The levels of anti-collagen antibodies were not however significantly enhanced by MDP. Radiological lesions and histological changes were maximal at high dosage regimens. Paradoxically, the acute phase reactive alpha 1 glycoprotein was little affected by MDP treatment.
Complete list of metadata

https://hal.univ-lorraine.fr/hal-01707374
Contributor : Jean-Yves JOUZEAU Connect in order to contact the contributor
Submitted on : Monday, February 12, 2018 - 5:20:20 PM
Last modification on : Tuesday, May 17, 2022 - 2:58:09 PM

Identifiers

Collections

Citation

J Jouzeau, E Drelon, G. Gillet, B Bannwarth, P. Fener, et al.. Influence of muramyl dipeptide on established experimental arthritis in rats.. Agents and actions. Supplements, 1991, pp.191-5. ⟨10.1007/978-3-0348-7405-2_26⟩. ⟨hal-01707374⟩

Share

Metrics

Record views

23